BNGO Crosses Above Average Analyst Target
December 31, 2020 at 08:29 AM EST
In recent trading, shares of BioNano Genomics Inc (BNGO) have crossed above the average analyst 12-month target price of $1.38, changing hands for $2.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..